Literature DB >> 29279175

MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.

Luciana Costa-Silva1, Silvia Marinho Ferolla2, Agnaldo Soares Lima3, Paula Vieira Teixeira Vidigal4, Teresa Cristina de Abreu Ferrari5.   

Abstract

OBJECTIVES: To evaluate the performance of magnetic resonance elastography (MRE) in diagnosing and staging hepatic fibrosis in patients with histologically confirmed nonalcoholic fatty liver disease (NAFLD) and in distinguishing simple steatosis from nonalcoholic steatohepatitis (NASH).
METHODS: Ninety subjects (49 NAFLD patients and 41 healthy volunteers) were prospectively enrolled. Liver stiffness measured by MRE was correlated with the grade of fibrosis and/or inflammation determined by liver biopsy. Correlations, ROC (receiver operator characteristic) curves and diagnostic performance were evaluated. The study was approved by the local ethics committee.
RESULTS: The area under the ROC curve (AUROC) of MRE in discriminating healthy from NAFLD individuals was 0.964 (P<0.0001), and that for distinguishing advanced (F3-F4) from absent/mild fibrosis (F0-F2) was 0.928 (P<0.0001). The use of a threshold >4.39 kPa resulted in a sensitivity of 90.9% and a specificity of 97.3% for diagnosing advanced fibrosis. For discriminating NASH from simple steatosis, the AUROC was 0.783 (P<0.0001), and the threshold, 3.22 kPa.
CONCLUSIONS: MRE is an effective, non-invasive method for detecting/staging hepatic fibrosis in NAFLD. This method has good performance in discriminating normal from NAFLD subjects and between the extreme grades of fibrosis. NAFLD patients with inflammation and without fibrosis have higher liver stiffness than those with simple steatosis.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Hepatic steatosis; Liver fibrosis; Magnetic resonance elastography; Nonalcoholic fatty liver disease; Steatohepatitis

Mesh:

Year:  2017        PMID: 29279175     DOI: 10.1016/j.ejrad.2017.11.003

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  14 in total

1.  Comparison of diffusion-weighted imaging and MR elastography in staging liver fibrosis: a meta-analysis.

Authors:  Weon Jang; Seongil Jo; Ji Soo Song; Hong Pil Hwang; Seong-Hun Kim
Journal:  Abdom Radiol (NY)       Date:  2021-03-26

Review 2.  MR elastography of liver: current status and future perspectives.

Authors:  Ilkay S Idilman; Jiahui Li; Meng Yin; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2020-07-23

3.  Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.

Authors:  Marco Dioguardi Burgio; Riccardo Sartoris; Aurélie Beaufrere; Jules Grégory; Boris Guiu; Chloé Guillot; Pierre-Emmanuel Rautou; Laurent Castera; Mohamed Bouattour; Valérie Paradis; Valérie Vilgrain; Maxime Ronot
Journal:  Eur Radiol       Date:  2021-09-17       Impact factor: 7.034

Review 4.  Liver fibrosis assessment: MR and US elastography.

Authors:  Arinc Ozturk; Michael C Olson; Anthony E Samir; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2021-10-23

Review 5.  Magnetic resonance elastography of the liver: everything you need to know to get started.

Authors:  Kay M Pepin; Christopher L Welle; Flavius F Guglielmo; Jonathan R Dillman; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2021-11-01

6.  Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging.

Authors:  N Verloh; U Probst; K Utpatel; F Zeman; F Brennfleck; J M Werner; C Fellner; C Stroszczynski; M Evert; P Wiggermann; M Haimerl
Journal:  PLoS One       Date:  2019-05-13       Impact factor: 3.240

Review 7.  Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).

Authors:  Hannah K Drescher; Sabine Weiskirchen; Ralf Weiskirchen
Journal:  Cells       Date:  2019-08-07       Impact factor: 6.600

Review 8.  Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy.

Authors:  Yuanzi Liang; Daowei Li
Journal:  BMC Gastroenterol       Date:  2020-04-06       Impact factor: 3.067

9.  Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index.

Authors:  Nikhil Makhija; Naval K Vikram; Gurdeep Kaur; Raju Sharma; Deep N Srivastava; Kumble S Madhusudhan
Journal:  J Clin Exp Hepatol       Date:  2019-09-20

10.  Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study).

Authors:  Anna Ozaki; Masato Yoneda; Takaomi Kessoku; Michihiro Iwaki; Takashi Kobayashi; Yasushi Honda; Yuji Ogawa; Kento Imajo; Eiji Sakai; Masataka Taguri; Takeharu Yamanaka; Tomoyuki Iwasaki; Takeo Kurihashi; Satoru Saito; Atsushi Nakajima
Journal:  Contemp Clin Trials Commun       Date:  2019-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.